Systematic review of outcome measures following chemoradiotherapy for the treatment of anal cancer (CORMAC).

Rebecca FishC SandersN RyanSabine N van der VeerA G RenehanP R Williamson

Published in: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland (2018)

Outcomes reported in studies evaluating chemoradiotherapy for ASCC were heterogenous and definitions varied widely. Outcomes likely to be important to patients, such as ano-rectal function, toxicity and QoL, have been neglected. A COS for future trials will address these issues.

Keyphrases

systematic review
rectal cancer
end stage renal disease
locally advanced
chronic kidney disease
newly diagnosed
ejection fraction
oxidative stress
papillary thyroid
high grade
type diabetes
metabolic syndrome
adipose tissue
young adults
skeletal muscle
case control
patient reported